🇺🇸 FDA
Pipeline program

HSV 2 Formulation 1

HSV15

Phase 1 mab terminated

Quick answer

HSV 2 Formulation 1 for Genital Herpes is a Phase 1 program (mab) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Lxo Ireland Designated Activity Company
Indication
Genital Herpes
Phase
Phase 1
Modality
mab
Status
terminated

Clinical trials